Your Best Stock

Pfizer PFE

$28.48
+$0.30 (+1.05%)
Market open · Sep 24, 1:10 pm ET
After hours $28.19 +0.02%
Open$28.20
Prev close$28.18
Day range$28.20 – $28.85
Volume18.08M
Market cap$162.27B
P/E (TTM)37.5
Dividend yield6.04%

Earnings

Average move on report day±2.1%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+6.1%
Worst reaction-3.3%

Stock move on the day after each report

+0.0%2023/Q3-1.7%2023/Q4+6.1%2024/Q1+2.2%2024/Q2-1.4%2024/Q3-1.3%2024/Q4+3.2%2025/Q1+5.2%2025/Q2-1.5%2025/Q3-3.3%2025/Q4+0.6%2026/Q1+1.5%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026±0.6%+1.52%Bigger than priced
2026/Q15 May 2026±0.9%+0.57%Within range
2025/Q43 Feb 2026±0.8%-3.34%Bigger than priced
2025/Q34 Nov 2025Pre Market±1.0%-1.46%Bigger than priced
2025/Q25 Aug 2025±1.2%+5.18%Bigger than priced
2025/Q129 Apr 2025±1.0%+3.21%Bigger than priced
2024/Q44 Feb 2025Pre Market±1.2%-1.26%Bigger than priced
2024/Q329 Oct 2024±1.2%-1.39%Bigger than priced
2024/Q230 Jul 2024±1.6%+2.18%Bigger than priced
2024/Q11 May 2024Pre Market±1.2%+6.09%Bigger than priced
2023/Q430 Jan 2024Pre Market±1.2%-1.67%Bigger than priced
2023/Q331 Oct 2023Pre Market±1.3%+0.03%Within range
2023/Q21 Aug 2023±1.3%-1.25%Within range
2023/Q12 May 2023±1.4%-0.38%Within range
2022/Q431 Jan 2023±2.1%+1.40%Within range
2022/Q31 Nov 2022±2.3%+3.14%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • BioPharma$14.66B 97.5%
  • Other business activities$373.00M 2.5%

Latest reported quarter: Q2, ended Jun 2026

Revenue$15.03B+2.6% YoY
Operating profit$3.54B-6.1% YoY
Net profit-$237.00M-108.1% YoY
Diluted EPS-$0.04-107.8% YoY
Free cash flow$302.00M+125.2% YoY
Operating cash flow$835.00M

Revenue, last 8 quarters

$17.7BSep '24$17.8BDec '24$13.7BMar '25$14.7BJun '25$16.7BSep '25$17.6BDec '25$14.5BMar '26$15.0BJun '26

Net profit, last 8 quarters

$4.5BSep '24$418.0MDec '24$3.0BMar '25$2.9BJun '25$3.6BSep '25$-1.6BDec '25$2.7BMar '26$-237.0MJun '26

Profitability & balance sheet

Gross margin73.2%
Operating margin26.7%
Net margin6.8%
Return on equity5.0%
Return on assets2.1%
Return on invested capital3.8%
Current ratio1.27
Liabilities / assets57.5%
Cash & investments$11.70B
Total debt$63.19B
Net cash (debt)-$51.50B
Free cash flow / sales17.2%
Scroll to Top